Table:
begin	end	state
1	29	cytoplasmic
30	48	transmembrane
49	53	non-cytoplasmic
54	72	transmembrane
73	102	cytoplasmic
103	124	transmembrane
125	142	non-cytoplasmic
143	161	transmembrane
162	171	cytoplasmic
172	192	transmembrane
193	211	non-cytoplasmic
212	234	transmembrane
235	254	cytoplasmic
255	277	transmembrane
278	300	non-cytoplasmic
301	323	transmembrane
324	344	cytoplasmic
345	362	transmembrane
363	366	non-cytoplasmic
367	391	transmembrane
392	403	cytoplasmic
404	425	transmembrane
426	426	non-cytoplasmic

Input:
>AO356_24385
MNDQANSVEERFETTVPATLSQWSRQDTTWMLGLFGTAIGAGTLFLPINAGLGGFWPLLI
LALLAFPMTFYAHRGLTRFVLSGRDGADITEVVEEHFGLKAGALITLLYFFAIFPILLIY
SVALTNTVGSFLEHQLHIQPPPRAVLSLVLILGLLAVVRCGEQAIVKAMSLMVYPFIVAL
LFLAVFLIPHWSGGILSTASTPPEPSALLHTLWLAIPVMVFSFNHSPIISAFAVDQKRRY
GANAEERSSQILSRAHVLMVVMVLFFVFSCVLTLTPAQLAEAKAQNLSILSYLANHFSNP
TIAFAAPLIAFVAISKSFLGHYIGASEGLKGLIVKSGRRPAPKTLDRLTAAFMLVVCWIV
ATLNPSILGMIETLGGPVIAAILFLMPMYAIRKVPAMARYRGQASNVFVVLVGLVAITAL
VYSLMA

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server